Active

MIVAPHARM

Switched

BE0473651691

Rechtspersoon Besloten Vennootschap 1 establishment

Active for

25 year, 3 months

Registered office

Rue Commandant Naessens 68

4431 Ans

België

Names & denominations

MIVAPHARM

Official name

FR

Enterprise details

Enterprise type

Rechtspersoon

Legal form

Besloten Vennootschap

Legal situation

Normale toestand

Start date

28 December 2000

Contact

Not specified

Peppol

Active
0208:0473651691

Active since 21 Nov 2025

Powered by

Databakkes.be

Company info. No nonsense.

Activities

NACE-BEL activity descriptions are currently shown in Dutch. English translations are underway.

NACE-BEL activities

What does this company officially do?

68110 Main activity

Handel in eigen onroerend goed

68100 Main activity

Handel in eigen onroerend goed

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

What are NACE codes? NACE-BEL is the Belgian version of the European activity nomenclature. Each company has at least one code indicating its main activity.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Commandant Naessens 68

4431 Ans

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Frequently asked questions

What is the enterprise number of MIVAPHARM?
The enterprise number of MIVAPHARM is BE0473651691.
What is the address of MIVAPHARM?
The registered office of MIVAPHARM is located at Rue Commandant Naessens 68, 4431 Ans.
When was MIVAPHARM founded?
MIVAPHARM was founded on 28 December 2000.
What is the main activity of MIVAPHARM?
The main activity of MIVAPHARM is "Handel in eigen onroerend goed" (NACE code 68110).
Does MIVAPHARM have a website?
No website is currently known for MIVAPHARM.